Skip to content
value.today

BioLife Solutions Inc.

Total raised
$10 M
1 round on record
Latest round
$10 M
Oct 2023
First round on record
Oct 2023
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of BioLife Solutions Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2023$10 MNo. 1$10 to $50 million

BioLife Solutions Inc.: Raise no. 1, Oct 2023

Investors in this round

1 investor had bought by the notice of Oct 27, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for BioLife Solutions Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aby Mathew · Executive Officer
  • Geraint Phillips · Executive Officer
  • Karen Foster · Executive Officer
  • Michael Rice · Executive Officer, Director · Resigned from his position of CEO and Chair of the Board following the closing of the offering.
  • Roderick De Greef · Executive Officer, Director · Was appointed as CEO and Chair of the Board following the closing of the offering.
  • Sarah Aebersold · Executive Officer
  • Todd Berard · Executive Officer
  • Troy Wichterman · Executive Officer
  • Amy DuRoss · Director
  • Joseph Schick · Director
  • Joydeep Goswami · Director
  • Rachel Ellingson · Director
  • Tim Moore · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Troy Wichterman, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 27, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • BioLife Solutions Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2023).

    SEC Form D · Oct 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2023

That is all the official record says: BioLife Solutions Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in BioLife Solutions Inc.
InvestorKindAmountRoundRoleSource
Walter VilligerPersonnot statednot statedHeld Series F preferred stock, 10% owner (Form 3, 2013)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 1 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by BioLife Solutions Inc.
NameRoleNamed in
Aby MathewExecutive officerOct 2023
Geraint PhillipsExecutive officerOct 2023
Karen FosterExecutive officerOct 2023
Michael RiceResigned from his position of CEO and Chair of the Board following the closing of the offering.Oct 2023
Roderick De GreefWas appointed as CEO and Chair of the Board following the closing of the offering.Oct 2023
Sarah AebersoldExecutive officerOct 2023
Todd BerardExecutive officerOct 2023
Troy WichtermanExecutive officerOct 2023
Amy DuRossDirectorOct 2023
Joseph SchickDirectorOct 2023
Joydeep GoswamiDirectorOct 2023
Michael RiceResigned from his position of CEO and Chair of the Board following the closing of the offering.Oct 2023
Rachel EllingsonDirectorOct 2023
Roderick De GreefWas appointed as CEO and Chair of the Board following the closing of the offering.Oct 2023
Tim MooreDirectorOct 2023